Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Globus Medical Inc shares valued at $1,668,780 were sold by Kline Kyle on Dec 01 ’25. At $90.00 per share, Kline Kyle sold 18,542 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Kline Kyle purchased 18,542 shares, netting a total of over 1,667,847 in proceeds.
Before that, Huller Kelly had sold 7,500 shares from its account. In a trade valued at $675,000, the SVP, GC, Corporate Secretary traded Globus Medical Inc shares for $90.00 each. Upon closing the transaction, the insider’s holdings decreased to 7,500 shares, worth approximately $0.0.
As published in a research note from Truist on November 07, 2025, Globus Medical Inc [GMED] has been rated up from a Hold to a Buy and the price target has been revised to $93. Analysts at BofA Securities upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in early November. Earlier on May 27, 2025, BTIG Research downgraded its rating. Their new recommendation was “a Neutral” for GMED stock which previously was a “a Buy”.
Analyzing GMED Stock Performance
On last trading session, Globus Medical Inc [NYSE: GMED] rose 1.13% to $88.74. The stock’s lowest price that day was $87.2, but it reached a high of $89.13 in the same session. During the last five days, there has been a drop of approximately -2.57%. Over the course of the year, Globus Medical Inc shares have jumped approximately 5.77%. Shares of the company reached a 52-week high of $94.93 on 01/30/25 and a 52-week low of $51.79 on 08/01/25.
Support And Resistance Levels for Globus Medical Inc (GMED)
According to the 24-hour chart, there is a support level at 87.58, which, if violated, would cause prices to drop to 86.43. In the upper region, resistance lies at 89.51. The next price resistance is at 90.29. RSI (Relative Strength Index) is 70.77 on the 14-day chart, showing overbought technical sentiment.
Is Globus Medical Inc subject to short interest?
Stocks of Globus Medical Inc saw a sharp steep in short interest on 2025-11-14 dropping by -1.51 million shares to 4.82 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 6.33 million shares. A decline of -31.23% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.35 of the overall float, the days-to-cover ratio (short ratio) decline to 2.35.
Which companies own the most shares of Globus Medical Inc (GMED)?
In terms of Globus Medical Inc share price expectations, FactSet research, analysts set an average price target of 76 in the next 12 months, down nearly -13.39% from the previous closing price of $87.75. Analysts anticipate Globus Medical Inc stock to reach 88 by 2025, with the lowest price target being 64. In spite of this, 10 analysts ranked Globus Medical Inc stock as Buy at the end of 2025. On January 10, 2025, BofA Securities assigned a price target of “a Neutral” to the stock and upgraded coverage with a $97.
